Previous close | 21.36 |
Open | 21.39 |
Bid | 22.33 x 100 |
Ask | 22.56 x 100 |
Day's range | 21.37 - 22.86 |
52-week range | 18.45 - 37.71 |
Volume | |
Avg. volume | 707,016 |
Market cap | 938.742M |
Beta (5Y monthly) | 1.72 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.08 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 35.00 |
SEATTLE, April 19, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 first quarter after the market closes on Thursday, May 2, 2024. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast, to include a slide presentation, will be available on Trupanion's Investor Relations site under Investor Events at http://investo
SEATTLE, April 17, 2024--Trupanion, Inc. (Nasdaq: TRUP) received the following awards at the 18th annual Stevie Awards for Sales & Customer Service:
SEATTLE, April 16, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, has published its 2023 annual shareholder letter, co-written by CEO and Chair, Darryl Rawlings, and President, Margi Tooth. The letter is now available on the Company’s Investor Relations website here. About Trupanion Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, Europe, Puerto Rico and Australia with over 1,